Description
N/A
Screenshots
Medvise AI FAQ
-
Is Medvise AI free?
Yes, Medvise AI is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Medvise AI legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Medvise AI cost?
Medvise AI is free.
-
What is Medvise AI revenue?
To get estimated revenue of Medvise AI app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
Medvise AI Reviews
No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Medvise AI Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
CascadeMD
Transcribe medical dictation
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago | |
Sniffle for Providers
Ai Driven Virtual Care.
|
Unlock
|
Unlock
|
0
|
|
10 months ago | |
DRUGDOCS
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
EuroTeleMedicine
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
MedicPad Clinic
Patient Management System
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
medAiLOG
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
Chatdok
|
Unlock
|
Unlock
|
0
|
|
11 months ago | |
Ana!
Ana
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
Quantum Health Ambient Scribe
Generative AI Medical Notes
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
DentScribe
|
Unlock
|
Unlock
|
0
|
|
1 month ago |
Medvise AI Installs
Last 30 days
Medvise AI Revenue
Last 30 daysMedvise AI Revenue and Downloads
Gain valuable insights into Medvise AI performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Medvise
- Languages
- English
- Recent release
- 1.1.3 (9 months ago )
- Released on
- Feb 26, 2024 (10 months ago )
- Also available in
- United States , India , Philippines , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Latvia , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , South Africa , Pakistan , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Slovakia , Türkiye , Taiwan , Ukraine , United Arab Emirates , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , Italy , Dominican Republic , Algeria , Ecuador , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.